Product image of Adzynma (Radamts13) supplied by GNH India

Adzynma

Active Ingredient:
Radamts13
Origin:
EU

Adzynma (Radamts13)

Adzynma (Radamts13) is an intravenous medication used for specific therapeutic purposes. Learn about its uses, effects, and precautions in this comprehensive guide.

Manufacturer / TM Owner

Takeda Manufacturing Austria Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Adzynma (Radamts13) is primarily used for therapeutic purposes related to certain medical conditions. It is administered intravenously to address specific health needs. The medication is designed to target particular physiological processes, making it a valuable option for patients requiring intravenous treatment.

Side Effects

  • Adzynma (Radamts13) may cause various effects depending on individual patient responses. Common effects can include reactions at the injection site or general systemic responses. Patients should monitor their health and report any unusual symptoms to their healthcare provider.

Precautions & Warnings

  • When handling Adzynma (Radamts13), it is important to follow proper storage and administration guidelines. The medication should be stored according to the manufacturer's instructions to maintain its efficacy. Patients should be aware of potential allergies or sensitivities to the components of the medication.

Avoid Interactions

  • Adzynma (Radamts13) may interact with other medications or substances. Patients should inform their healthcare provider about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions. Alcohol and certain foods may also affect the medication's efficacy.

Frequently Asked Questions

Adzynma (Radamts13) is used for specific therapeutic purposes related to certain medical conditions, administered intravenously.

Adzynma (Radamts13) is administered intravenously, meaning it is delivered directly into the bloodstream.

Common effects of Adzynma (Radamts13) can include reactions at the injection site or general systemic responses.

Patients should follow proper storage and administration guidelines and be aware of potential allergies or sensitivities to the medication's components.

Yes, Adzynma (Radamts13) may interact with other medications or substances, so patients should inform their healthcare provider about all current medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Radamts13

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT